Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,474,671.30
- Nov. 18, 2024
- Isaac E Ciechanover
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 9, 2018 | CEO | 8,800 | $37.44 | Sell | $329,472.00 | |
Feb. 9, 2018 | EVP | 12,214 | $38.01 | Sell | $464,254.14 | |
Jan. 26, 2018 | CEO | 19,300 | $35.26 | Sell | $680,518.00 | |
Jan. 24, 2018 | CEO | 48,500 | $34.58 | Sell | $1,677,130.00 | |
Jan. 22, 2018 | CEO | 10,000 | $33.07 | Sell | $330,700.00 | |
Jan. 16, 2018 | CEO | 600 | $30.38 | Sell | $18,228.00 | |
Jan. 12, 2018 | CEO | 28,700 | $21.39 | Sell | $613,893.00 | |
Jan. 12, 2018 | CFO | 37,000 | $24.35 | Sell | $900,950.00 | |
Jan. 10, 2018 | CEO | 8,600 | $19.99 | Sell | $171,914.00 | |
Dec. 29, 2017 | CEO | 22,200 | $18.29 | Sell | $406,038.00 | |
Dec. 29, 2017 | CFO | 32,000 | $20.00 | Sell | $640,000.00 | |
Dec. 29, 2017 | CFO | 32,000 | $20.00 | Sell | $640,000.00 | |
Dec. 28, 2017 | CEO | 2,200 | $15.15 | Sell | $33,330.00 | |
Dec. 13, 2017 | CEO | 4,400 | $14.65 | Sell | $64,460.00 | |
Nov. 30, 2017 | CEO | 4,400 | $14.25 | Sell | $62,700.00 | |
Nov. 17, 2017 | EVP | 7,000 | $15.00 | Sell | $105,000.00 | |
Nov. 16, 2017 | Director | 1,184 | $14.20 | Sell | $16,812.80 | |
Nov. 15, 2017 | EVP | 1,604 | $13.36 | Sell | $21,429.44 | |
Nov. 14, 2017 | CEO | 4,400 | $13.47 | Sell | $59,268.00 | |
Oct. 27, 2017 | CEO | 4,400 | $13.59 | Sell | $59,796.00 | |
Oct. 16, 2017 | EVP | 6,000 | $14.35 | Sell | $86,100.00 | |
Oct. 12, 2017 | CEO | 4,400 | $15.02 | Sell | $66,088.00 | |
Oct. 11, 2017 | CEO | 2,200 | $15.25 | Sell | $33,550.00 | |
Sept. 20, 2017 | CEO | 4,400 | $15.54 | Sell | $68,376.00 | |
Sept. 15, 2017 | EVP | 6,000 | $15.30 | Sell | $91,800.00 | |
Sept. 7, 2017 | CEO | 4,400 | $15.02 | Sell | $66,088.00 | |
Aug. 23, 2017 | CEO | 4,400 | $13.54 | Sell | $59,576.00 | |
Aug. 16, 2017 | EVP | 3,021 | $14.33 | Sell | $43,290.93 | |
Aug. 16, 2017 | CFO | 4,200 | $14.31 | Sell | $60,102.00 | |
Aug. 16, 2017 | Director | 1,184 | $14.30 | Sell | $16,931.20 | |
Aug. 15, 2017 | EVP | 7,604 | $14.75 | Sell | $112,159.00 | |
Aug. 11, 2017 | CEO | 4,400 | $14.67 | Sell | $64,548.00 | |
July 25, 2017 | CEO | 5,500 | $16.49 | Sell | $90,695.00 | |
July 24, 2017 | CEO | 2,800 | $16.94 | Sell | $47,432.00 | |
July 17, 2017 | EVP | 6,000 | $14.92 | Sell | $89,520.00 | |
June 15, 2017 | EVP | 6,000 | $12.65 | Sell | $75,900.00 | |
June 9, 2017 | Director | 1,000 | $13.15 | Sell | $13,150.00 | |
May 31, 2017 | CEO | 6,900 | $13.35 | Sell | $92,115.00 | |
May 30, 2017 | CEO | 3,450 | $13.44 | Sell | $46,368.00 | |
May 18, 2017 | CEO | 4,800 | $14.91 | Sell | $71,568.00 | |
May 16, 2017 | CFO | 4,000 | $15.11 | Sell | $60,440.00 | |
May 16, 2017 | Director | 1,184 | $15.25 | Sell | $18,056.00 | |
May 16, 2017 | EVP | 12,674 | $15.16 | Sell | $192,137.84 | |
April 26, 2017 | CEO | 7,200 | $17.56 | Sell | $126,432.00 | |
April 25, 2017 | CEO | 3,600 | $17.33 | Sell | $62,388.00 | |
April 17, 2017 | EVP | 6,000 | $17.28 | Sell | $103,680.00 | |
April 11, 2017 | CEO | 7,200 | $17.03 | Sell | $122,616.00 | |
March 28, 2017 | CEO | 16,000 | $20.06 | Sell | $320,960.00 | |
March 23, 2017 | CFO | 14,000 | $20.65 | Sell | $289,100.00 | |
March 17, 2017 | CEO | 30,800 | $19.38 | Sell | $596,904.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Pascal Touchon, Utpal Koppikar, Gad Soffer, Amar Murugan, Jakob Dupont, Eric J Hyllengren, Mitchall G Clark, Anhco Nguyen, Derrell Porter, Joel S Marcus, Eric Dobmeier, Kristin Yarema, Matthew K Fust, Mitchall G. Clark, Jill Henrich, Heather D Turner, William K Heiden, Domain Partners Viii, L.P., and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.